Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Netherlands Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20032
20044
20063
20073
20082
20101
20113
20123
20134
20142
20154
20162
20172
20182
20196
20202
20212
20221
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting8
Terminated8
Active, not recruiting6
Withdrawn3
Unknown status3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Netherlands Cancer Institute10
University Medical Center Groningen6
Borstkanker Onderzoek Groep5
Novartis Pharmaceuticals4
European Organisation for Research and Treatment of Cancer - EORTC3
Eli Lilly and Company2
Erasmus Medical Center2
Hoffmann-La Roche2
Maastricht University Medical Center2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms58
Neoplasm Metastasis13
Lung Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Cardiotoxicity2
Cholangiocarcinoma2
Colorectal Neoplasms2
Glioma2

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.